KMTS — Kestra Medical Technologies, Ltd. Stock Price, Chart & AI Report

Positive Mar 25, 2026 • 12:00 UTC GlobeNewswire Inc. • Na

Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”

Kestra Medical Technologies (Nasdaq: KMTS), a wearable medical device and digital healthcare company, has been named a finalist in the 'Deal of the Year' category for the 2026 GeekWire Awards. The recognition is for the company's successful 2025 initial public offering, which the company states strengthens its ability to invest in growth and accelerate progress toward new standards of care for cardiac patients. Community voting is open through April 16, 2026, with winners to be announced on May 7, 2026.

KMTS wearable medical device digital healthcare initial public offering Cardiac Recovery System GeekWire Awards cardiovascular disease sudden cardiac arrest

Sentiment note

The company received recognition as a finalist for a prestigious industry award for its IPO, which is described as a successful milestone that strengthens the company's financial position for growth and innovation. The CEO's statement emphasizes momentum and progress toward clinical objectives.

Neutral Dec 30, 2025 • 11:00 UTC GlobeNewswire Inc. • Na

Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026. The company focuses on transforming patient outcomes in cardiovascular disease through monitoring and therapeutic intervention technologies.

KMTS wearable medical device digital healthcare cardiovascular disease J.P. Morgan Healthcare Conference investor presentation

Sentiment note

The article is primarily informational, announcing a scheduled presentation at a major healthcare conference. There is no discussion of financial performance, product developments, or market challenges. The tone is factual and promotional in nature, neither indicating positive business developments nor negative concerns.

Neutral Dec 3, 2025 • 13:00 UTC GlobeNewswire Inc. • Na

Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results

Kestra Medical Technologies will report its second quarter fiscal 2026 financial results on December 11, with a conference call scheduled at 4:30 p.m. Eastern Time. The call will be available via webcast on their investor relations website.

KMTS financial results conference call medical technology earnings report

Sentiment note

The article is a standard financial reporting announcement with no explicit positive or negative indicators, presenting routine information about an upcoming earnings call

Neutral Dec 3, 2025 • 03:11 UTC GlobeNewswire Inc. • Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares

Kestra Medical Technologies is conducting a public offering of 6,000,000 common shares at $23.00 per share, expecting to raise $138 million. The offering includes an option for underwriters to purchase an additional 900,000 shares.

KMTS PIPR public offering common shares medical device financing

Sentiment note

The company is raising capital through a standard public offering, which indicates a strategic financial move to support business growth without signaling significant positive or negative implications

Neutral Dec 1, 2025 • 12:16 UTC Benzinga • Globe Newswire

Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares

Kestra Medical Technologies plans to offer 5,500,000 common shares through an underwritten public offering, with potential for an additional 825,000 shares. The proceeds will support sales, marketing, research, development, and general corporate purposes.

KMTS PIPR WFC WFCPA public offering medical device digital healthcare stock issuance

Sentiment note

The company is conducting a standard public offering to raise capital for business growth and operations, which is a typical financial strategy without strong positive or negative implications

Neutral Sep 11, 2025 • 21:00 UTC The Motley Fool • Motley Fool Markets Team

Kestra Revenue Jumps 52% in Fiscal Q1

Kestra Medical Technologies reported a 52% revenue increase in Q1 FY2026, driven by rising ASSURE wearable defibrillator prescriptions. Despite strong top-line growth, the company experienced widening losses and increased operating expenses.

KMTS medical technology wearable defibrillator cardiac care healthcare innovation

Sentiment note

Mixed performance with strong revenue growth (52%) offset by increased operating expenses and widening net losses. Positive signs include improved gross margin and expanded insurance coverage, but concerns exist about cost management and path to profitability.

Positive Mar 7, 2025 • 22:30 UTC GlobeNewswire Inc. • N/A

Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering

Kestra Medical Technologies, Ltd. (KMTS) announced the closing of its upsized initial public offering, raising approximately $202 million. The company's shares began trading on the Nasdaq Global Select Market.

KMTS Kestra Medical Technologies IPO Nasdaq wearable medical devices digital healthcare

Sentiment note

The company successfully completed its upsized IPO, raising a significant amount of capital, which suggests a positive outlook for the company's growth and development.